Fundraising Fox

Arbutus

Founded 2014 · 40 employees on LinkedIn · 3 known investors

Vancouver medtech converting power tools into sterile surgical drills and selling sterile-packed orthopedic procedure kits.

Also known as Arbutus Medical · Arbutus Medical Inc.

Investors · 3

Company profile

researched Aug 2026

Arbutus Medical Inc. is a Vancouver, British Columbia medical device company that designs and distributes orthopedic surgical drills and sterile-packed procedure kits. Its core patented DrillCover technology is an autoclavable cover that allows a commercial power tool to be used as a sterile surgical drill; the covered drill has been licensed as a surgical device since 2015. Products include the HEX Drill Kit (based on a Stanley Black & Decker drill) and the PRO Drill Kit (based on a Makita cannulated drill), both registered and licensed as surgical devices, plus consumable procedure kits: TrakPak for skeletal traction and the Digit Revision SwiftKit for fingertip revision amputation procedures. The company also references QuikLine.

The company positions its products for use outside as well as inside the operating room, serving trauma center emergency departments and ICUs, hospital operating rooms, NGOs, veterinarians and military field medicine. Its stated mission is to simplify surgery to reduce cost and allow providers to treat more patients, with an emphasis on avoiding large capital expenditures for hospitals. Devices are FDA-cleared and licensed by Health Canada, and the company holds an ISO 13485 (2016) certificate for the design and distribution of medical devices.

Arbutus Medical was founded in 2014 by orthopaedic trauma surgeons from Vancouver General Hospital together with biomedical researchers from the University of British Columbia, and takes its name from a tree native to Canada's west coast. Co-founder Lawrence Buchan was appointed CEO in 2018; co-founder Michael Cancilla serves as Senior Director of Product. The board includes Ray Muzyka (ThresholdImpact), Paul Geyer (Nimbus Synergies), Marie-Claude Jacques (Catheter Precision) and Robert Ritlop (Crédit Mutuel Equity), and a medical advisory board of orthopaedic surgeons including founding advisors Peter O'Brien, Scott Nelson and Jeffrey Potter.

Founding story

Arbutus Medical was founded in 2014 after orthopaedic trauma surgeons from Vancouver General Hospital and a team of biomedical researchers developed a surgical drill technology and formed a partnership with DEWALT, aimed at giving low-resource hospitals an affordable, reliable and sterile option for orthopedic surgery. Co-founder Lawrence Buchan started the company alongside research colleagues from the University of British Columbia and became CEO in 2018. The company is named after the arbutus tree, native to the west coast of Canada where it is based.

Business model

Arbutus Medical sells surgical drill kits built on adapted commercial power tools together with consumable, sterile-packed procedure kits, bundling the drills with recurring consumables (such as razors and blades). Its stated advantage is intellectual property that allows DEWALT power tools to be adapted into sterile surgical drills for hospital and field settings, and the model is presented as helping hospitals avoid large capital expenditures. With TrakPak, the skeletal traction kit is sold with a surgical drill kit provided at no cost.

Revenue comes from sales of surgical drill kits and recurring, single-use sterile-packed procedure kits to hospitals and other care providers; a Gust profile reports approximately C$700K/yr in annual recurring revenue from US customers and about $500K in trailing-twelve-month revenue.

Traction

Products have been delivered to customers in 40 countries and are estimated to have enabled about 85,000 surgeries. The first procedure kit launched in 2021, and the US customer base is reported to have grown fourfold since December 1, 2021, reaching roughly C$700K per year in annual recurring revenue, with about $500K in trailing-twelve-month revenue and 13 employees. The company has announced a C$9.3M raise to accelerate growth of surgical workflow solutions outside the operating room, and CEO Lawrence Buchan is reported to have raised over $5M for the company.

Latest developments

Recent company updates include a C$9.3M raise to accelerate growth of surgical workflow solutions outside the operating room, the launch of the Digit Revision SwiftKit for fingertip revision amputation intended to improve emergency department throughput, and a post on QuikLine.

Full profile — market position, technology, go-to-market, geography, history

Market position

The company describes an established base of orthopedic customers across 40 countries, with its first procedure kit (skeletal traction) launched in 2021 and an expansion toward workflow solutions used outside the operating room. Gust materials name Conmed as an industry competitor.

Differentiation rests on patented DrillCover technology and IP enabling commercial power tools to be converted into licensed, registered surgical drills, paired with sterile-packed consumable procedure kits that streamline specific procedures such as skeletal traction and fingertip revision amputation, reducing the need for hospital capital purchases.

Technology

The patented DrillCover technology is an autoclavable cover that provides sterility while extending the life of the underlying power tool, enabling commercial drills from manufacturers such as DEWALT, Stanley Black & Decker and Makita to be licensed and registered as surgical devices. Products are described as robust, light and portable. The company's devices are FDA-cleared and licensed by Health Canada, and it maintains an ISO 13485 (2016)-certified quality management system for design and distribution of medical devices.

Go-to-market

Arbutus Medical sells directly to hospitals and care providers, with a dedicated trauma center sales function, and supports customer inquiries and quote requests through its website. It bundles no-cost drill kits with consumable procedure kits to ease adoption, and works with NGO, veterinary and military channels. The company is an alumnus of the Canadian Trade Accelerator in Boston/Cambridge, a program funded by Global Affairs Canada.

Trauma center emergency departments and intensive care units, hospital operating rooms, NGOs, veterinarians and military field medicine teams, including low-resource hospitals.

Geography

Headquartered at 2520 Columbia St, Vancouver, British Columbia, Canada, with products delivered to customers in 40 countries and a growing United States customer base.

History

Founded in 2014 (incorporated December 2014) out of collaboration between Vancouver General Hospital orthopaedic trauma surgeons and University of British Columbia biomedical researchers, the company's drill technology was licensed as a surgical device in 2015. Lawrence Buchan was appointed CEO in 2018. Arbutus Medical launched its first sterile-packed procedure kit, TrakPak for skeletal traction, in 2021, later added the Digit Revision SwiftKit for fingertip revision amputation, and announced a C$9.3M financing to expand surgical workflow solutions used outside the operating room.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Capital raised by CEO for the companyJan 2026over $5M
Countries with product deliveriesJan 202640
EmployeesJan 202613 people
Estimated surgeries enabledJan 202685,000 surgeries
TTM revenueJan 2026$500K
US annual recurring revenueJan 2026$700K
US customer base growth since 2021-12-01Jan 20264x

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 7

launches, deals, and filings
Jan 2026
Arbutus Medical raises C$9.3M to accelerate growth of surgical workflow solutions outside the OR

Company news post announcing a C$9.3M raise to accelerate growth of surgical workflow solutions used outside the operating room.

source ↗

Jan 2026
Launch of Digit Revision SwiftKit

Sterile-packed kit that streamlines fingertip revision amputation procedures, positioned to improve emergency department throughput.

source ↗

Jan 2021
First procedure kit launched (TrakPak skeletal traction)

Arbutus Medical launched its first sterile-packed procedure kit for skeletal traction.

source ↗

Jan 2018
Co-founder Lawrence Buchan appointed CEO

source ↗

Jan 2016
ISO 13485 (2016) certification for design and distribution of medical devices

source ↗

Jan 2015
DrillCover technology licensed as a surgical device

DrillCover technology licensed as a surgical device; company devices are FDA-cleared and licensed by Health Canada.

source ↗

Jan 2014
Partnership with DEWALT for adapted surgical drill technology

Founding partnership with DEWALT to adapt power tools into sterile surgical drills for low-resource hospitals.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Arbutus do?
Vancouver medtech converting power tools into sterile surgical drills and selling sterile-packed orthopedic procedure kits.
Who are Arbutus's investors?
Arbutus's investors include ScaleGood Fund LP (powered by TELUS), Sorenson Impact Foundation, WUTIF Capital.